Table 2.
Hemoglobin (Hb) variability by route of erythropoietin administration
Variable | Intravenous group (n = 38) | Subcutaneous group (n = 33) | p-value |
---|---|---|---|
Hb of >12, <9 g/dL (n/visit) | 0.27 ± 0.12 | 0.36 ± 0.19 | 0.03 |
Hb excursion (≥1.5) (n/visit) | 0.20 ± 0.08 | 0.17 ± 0.12 | 0.27 |
Standard deviation of Hb | 0.97 ± 0.23 | 1.02 ± 0.28 | 0.43 |
Residual standard deviation of Hb | 0.90 ± 0.23 | 0.97 ± 0.36 | 0.31 |
Coefficient of Hb variation | 0.10 ± 0.02 | 0.11 ± 0.03 | 0.15 |
ESA responsiveness index (U/kg/week/g/dL) | 10.9 ± 3.0 | 11.7 ± 4.8 | 0.61 |
Data expressed as mean ± standard deviation
ESA, erythropoiesis-stimulating agent.